CAG
GILD icon

Csenge Advisory Group’s Gilead Sciences GILD Stock Holding History

Csenge Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Buy
22,416
+4,314
+24% +$568K 0.11% 164
2026
Q1 		$2.52M Sell
18,102
-4,015
-18% -$562K 0.12% 159
2025
Q4 		$2.71M Buy
22,117
+723
+3% +$87.9K 0.12% 152
2025
Q3 		$2.37M Buy
21,394
+16,288
+319% +$1.85M 0.11% 158
2025
Q2 		$562K Buy
+5,106
New +$543K 0.03% 398
2025
Q1 		– Sell
-2,442
Closed -$226K – 692
2024
Q4 		$226K Sell
2,442
-3,197
-57% -$288K 0.01% 629
2024
Q3 		$479K Sell
5,639
-1,504
-21% -$115K 0.03% 433
2024
Q2 		$490K Sell
7,143
-1,288
-15% -$86K 0.03% 407
2024
Q1 		$618K Sell
8,431
-5,932
-41% -$456K 0.03% 380
2023
Q4 		$1.16M Buy
14,363
+547
+4% +$42.6K 0.07% 210
2023
Q3 		$1.04M Buy
13,816
+1,219
+10% +$93.8K 0.07% 205
2023
Q2 		$971K Buy
12,597
+1,674
+15% +$134K 0.07% 217
2023
Q1 		$906K Buy
10,923
+379
+4% +$31.4K 0.07% 226
2022
Q4 		$905K Buy
10,544
+1,575
+18% +$125K 0.07% 228
2022
Q3 		$553K Sell
8,969
-574
-6% -$36.2K 0.05% 313
2022
Q2 		$590K Buy
9,543
+4,032
+73% +$250K 0.05% 311
2022
Q1 		$328K Buy
+5,511
New +$352K 0.03% 480
2018
Q4 		– Sell
-216
Closed -$15K – 680
2018
Q3 		$15K Buy
+216
New +$16.3K 0.01% 419

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Csenge Advisory Group's GILD Position: Q2 2026 in Review

Csenge Advisory Group increased its Gilead Sciences (GILD) stake by 24% in Q2 2026, buying an estimated $568K and bringing the position to 22,416 shares worth $2.83M. The position accounts for 0.11% of the portfolio, ranked #164.

Csenge Advisory Group first reported a position in GILD in Q3 2018 and has held it in 18 quarters since. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Csenge Advisory Group held 22,416 shares of Gilead Sciences worth $2.83M as of Q2 2026.
  • Csenge Advisory Group bought 4,314 Gilead Sciences shares in Q2 2026, an estimated $568K.
  • Gilead Sciences made up 0.11% of Csenge Advisory Group's portfolio in Q2 2026, its #164 holding.
  • Csenge Advisory Group first reported a position in Gilead Sciences in Q3 2018 and has held it in 18 quarters since.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.